Search
Recursion Pharmaceuticals Inc
RXRXAdd to Watchlist
4.055USD
+0.255+6.71%
Market hours 10/27, 12:38（ET）
2.41BMarket Cap
LossP/E TTM
Today
+6.71%
5 Days
+12.33%
1 Month
+8.42%
6 Months
+15.53%
Year to Date
-0.86%
1 Year
-32.86%
Key Figures
3.805Open
4.110High
1.28MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.21%Turnover Ratio
3.800Prev. Close
3.640Low
5.07MTurnover
LossP/E Static
2.64P/B
0.00%Div Yield TTM
-42.33%ROA
6.25052wk High
0.14Volume Ratio
-463.66MNet Profit
594.73MShares
-1.1603EPS TTM
1.03Beta
-57.16%ROE
2.77052wk Low
12.37%Amplitude
-49.82%Gross Margin
2.41BMarket Cap
2.27Reward/Risk
4.61%Risk Rate
Recursion Pharmaceuticals Inc's Score
0.07vs previous score
Forecast6.86
Financial Health6.04
Technical5.27
Valuation Dimensions6.92
Institutional Confidence7.00
Risk Assessment3.57
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Recursion Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.25/-0.23
Revenue / Forecast
7.67M/11.95M
Recursion Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolRXRX
Number of employees840
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| ARK Investment Management LLC | 7.66% |
| BlackRock Institutional Trust Company, N.A. | 6.06% |
| State Street Investment Management (US) | 5.43% |
| Baillie Gifford & Co. | 4.51% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 40.50% |
| Investment Advisor/Hedge Fund | 12.87% |
| Venture Capital | 4.66% |
| Hedge Fund | 3.10% |
Related Instruments
+0.16%
+0.47%
+0.09%
+1.24%
+1.20%
-0.79%
+0.66%
-0.49%
-1.09%
-0.20%
-0.40%
-0.33%
-1.87%
+0.11%
+0.08%
+0.39%
-0.46%
-0.64%
-1.47%
+0.25%Popular Instruments
52385.200
+52.800 (+0.10%)
29660.600
+359.500 (+1.23%)
7724.000
+46.900 (+0.61%)
13001.000
-39.000 (-0.30%)
64316.000
+1537.000 (+2.45%)
6163.500
+67.300 (+1.10%)
99.642
-1.318 (-1.30%)
346.380
+2.470 (+0.72%)
218.130
+2.130 (+0.99%)
4060.350
+43.770 (+1.09%)
FAQs
What is the current price of Recursion Pharmaceuticals Inc (RXRX)?
The current price of Recursion Pharmaceuticals Inc (RXRX) is 3.80.
What is the symbol of Recursion Pharmaceuticals Inc?
The ticker symbol of Recursion Pharmaceuticals Inc is RXRX.
What is the 52-week high of Recursion Pharmaceuticals Inc?
The 52-week high of Recursion Pharmaceuticals Inc is 6.25.
What is the 52-week low of Recursion Pharmaceuticals Inc?
The 52-week low of Recursion Pharmaceuticals Inc is 2.77.
What is the market capitalization of Recursion Pharmaceuticals Inc?
The market capitalization of Recursion Pharmaceuticals Inc is 2.26B.
Is Recursion Pharmaceuticals Inc (RXRX) currently rated as Buy, Hold, or Sell?
According to analysts, Recursion Pharmaceuticals Inc (RXRX) has an overall rating of signal_hold, with a price target of 6.78.
What is the Earnings Per Share (EPS TTM) of Recursion Pharmaceuticals Inc (RXRX)?
The Earnings Per Share (EPS TTM) of Recursion Pharmaceuticals Inc (RXRX) is -1.16.